Overview

Cognitive Protection - Dexmedetomidine and Cognitive Reserve

Status:
Terminated
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This is a pilot study to evaluate the effect of dexmedetomidine in the prevention of delirium in non-cardiac surgical patients. The preliminary data regarding the effect of dexmedetomidine on delirium comes from a study underway at Stanford. We propose to randomize fifty patients into two different protocols, one using dexmedetomidine until PACU discharge (hip replacement) and the other using dexmedetomidine for 24 hours in a monitored setting.
Phase:
Phase 4
Details
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Treatments:
Dexmedetomidine